Head to Head Analysis: KDDI (OTCMKTS:KDDIY) and Avivagen (OTCMKTS:VIVXF)

Avivagen (OTCMKTS:VIVXFGet Free Report) and KDDI (OTCMKTS:KDDIYGet Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, profitability, risk, earnings, dividends and institutional ownership.

Valuation and Earnings

This table compares Avivagen and KDDI”s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Avivagen $730,000.00 0.00 -$4.71 million N/A N/A
KDDI $39.86 billion 1.93 $4.40 billion $1.01 17.42

KDDI has higher revenue and earnings than Avivagen.

Analyst Ratings

This is a breakdown of current recommendations for Avivagen and KDDI, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avivagen 0 0 0 0 0.00
KDDI 0 0 0 1 4.00

Given Avivagen’s higher probable upside, research analysts clearly believe Avivagen is more favorable than KDDI.

Profitability

This table compares Avivagen and KDDI’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Avivagen N/A N/A N/A
KDDI 10.71% 10.87% 4.03%

Volatility and Risk

Avivagen has a beta of -0.27, indicating that its stock price is 127% less volatile than the S&P 500. Comparatively, KDDI has a beta of 0.13, indicating that its stock price is 87% less volatile than the S&P 500.

Institutional and Insider Ownership

0.1% of KDDI shares are held by institutional investors. 2.1% of Avivagen shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

KDDI beats Avivagen on 9 of the 11 factors compared between the two stocks.

About Avivagen

(Get Free Report)

Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in Canada, Mexico, Brazil, the Philippines, Taiwan, and Thailand. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.

About KDDI

(Get Free Report)

KDDI Corporation provides telecommunications services in Japan and internationally. It operates in two segments, Personal Services and Business Services. The Personal Services segment offers telecommunication services and other services such as finance, energy, and LX through its multi-brands au, UQ mobile, and povo. The Business Services segment offers smartphones and other devices, network and cloud services, and data center services to corporate customers under the TELEHOUSE brand. The company was incorporated in 1984 and is headquartered in Tokyo, Japan.

Receive News & Ratings for Avivagen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avivagen and related companies with MarketBeat.com's FREE daily email newsletter.